Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.

BACKGROUND Oxidative stress has long been demonstrated in haemodialysis patients. However, the factors influencing their oxidative status have not been characterized extensively in these patients. Therefore, the present study was designed to investigate the influence of a large number of factors known to be associated with oxidative stress. METHODS In the present cross-sectional study, we determined the plasma levels of lipid and protein oxidation markers in 31 non-smoking haemodialysis patients and 18 non-smoking healthy subjects, together with various components of the antioxidant system at the plasma and erythrocyte level. RESULTS No influence of age, diabetes or iron overload on oxidative markers and plasma and erythrocyte antioxidant systems was detected in these haemodialysis patients. The lack of an association between iron overload and oxidative status may be related to the lower level of plasma ascorbate in haemodialysis patients, since ascorbate favours the generation of free iron from ferritin-bound iron. Interestingly, plasma C reactive protein (CRP) levels measured by highly sensitive CRP assay were correlated positively with plasma levels of thiobarbituric acid reactive substances (r=0.38, P<0.04) and negatively with plasma alpha-tocopherol levels (r=-0.46, P<0.01). Moreover, significant inverse correlations were observed between duration of dialysis treatment and plasma levels of alpha-tocopherol (r=-0.49, P<0.02) and ubiquinol (r=-0.40, P<0.05). CONCLUSIONS Our results suggest that inflammatory status and duration of dialysis treatment are the most important factors relating to oxidative stress in haemodialysis patients.

[1]  Z. Massy,et al.  Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. , 1999, Kidney international.

[2]  D. Tarng,et al.  Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. , 1999, Kidney international.

[3]  P. Stenvinkel,et al.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.

[4]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[5]  P. Jungers,et al.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.

[6]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[7]  J. Cristol,et al.  Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  G. London,et al.  Atherosclerosis and arteriosclerosis in chronic renal failure. , 1997, Kidney international.

[9]  Y. Wada,et al.  Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. , 1997, Kidney international.

[10]  P. McNamee,et al.  Susceptibility of VLDL to oxidation in patients on regular haemodialysis. , 1997, Atherosclerosis.

[11]  U. Beisiegel,et al.  Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. , 1997, Atherosclerosis.

[12]  T. Miyata,et al.  Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  C. Morris,et al.  Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin. , 1996, Biochimica et biophysica acta.

[14]  P. Jungers,et al.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.

[15]  P. Jungers,et al.  Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. , 1996, Free radical biology & medicine.

[16]  C. Combe,et al.  Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. , 1995, Nephron.

[17]  D. Girelli,et al.  Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. , 1994, The American journal of clinical nutrition.

[18]  G. Bellomo,et al.  Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? , 1994, Kidney international.

[19]  P. De Sole,et al.  Serum coenzyme Q10 in uremic patients on chronic hemodialysis. , 1994, Nephron.

[20]  L. Hunt,et al.  Comparative mortality from cardiovascular disease in patients with chronic renal failure. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  J. Paul,et al.  Lipid peroxidation abnormalities in hemodialyzed patients. , 1993, Nephron.

[22]  M. Kazatchkine,et al.  Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. , 1991, Nephron.

[23]  O. Aruoma,et al.  Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. , 1987, The Biochemical journal.

[24]  B. Descamps-Latscha,et al.  Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. , 1985, Kidney international.

[25]  Y. Yawata,et al.  Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis. , 1975, Blood.